Dodecanoate

Dodecanoate

SCHEMBL887841

CCCCCCCCCCCC(=O)O.OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.65
PPARG P37231 7/20 0.65
PPARD Q03181 7/20 0.65
PPARA Q07869 7/20 0.65
HDAC11 Q96DB2 5/20 0.65
TSHR P16473 5/20 0.65
PTPN1 P18031 3/20 0.65
KMT2A Q03164 3/20 0.65
ALDH1A1 P00352 2/20 0.65
TLR2 O60603 2/20 0.65
TDP1 Q9NUW8 2/20 0.65
FABP4 P15090 2/20 0.65
MEN1 O00255 2/20 0.65
ALOX15 P16050 2/20 0.65
HSD17B10 Q99714 2/20 0.65
SLC22A6 Q4U2R8 1/20 0.65
SLC22A8 Q8TCC7 1/20 0.65
ESR1 P03372 1/20 0.65
PDE4A P27815 1/20 0.65
PDE3A Q14432 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexaethylene Glycol SCHEMBL5145927 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11
Tetraethylene Glycol SCHEMBL7997286 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11
Triethylene Glycol SCHEMBL3322022 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11
Octanoic Acid SCHEMBL11237647 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11
Nonanoate SCHEMBL3124773 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11
Tridecanoate SCHEMBL4901631 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11
Octanoic Acid SCHEMBL23631740 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11
Tetraethylene Glycol SCHEMBL689010 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL1993427 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11
Pentaethylene Glycol SCHEMBL9014237 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4707362-A Sustained release composition BIOTEK, INC. (US) 1987-11-17 US claimed
US-11602582-B2 Intimate care lubricant compositions and methods for making same CHEMSIL SILICONES, INC. (CA) 2023-03-14 US disclosed
US-20210038637-A1 ANTIBACTERIAL AND SPERMICIDAL LUBRICANT BCSK BIOCID GMBH (AT) 2021-02-11 US disclosed
EP-3768809-A1 INTIMATE CARE LUBRICANT COMPOSITIONS AND METHODS FOR MAKING SAME Chemsil Silicones, Inc. (US) 2021-01-27 EP disclosed
EP-3749095-A1 ANTIBACTERIAL AND SPERMICIDAL LUBRICANT BCSK Biocid GmbH (AT) 2020-12-16 EP disclosed
WO-2019199394-A1 INTIMATE CARE LUBRICANT COMPOSITIONS AND METHODS FOR MAKING SAME CHEMSIL SILICONES, INC. (US) 2019-10-17 WO disclosed
US-20190307927-A1 INTIMATE CARE LUBRICANT COMPOSITIONS AND METHODS FOR MAKING SAME CHEMSIL SILICONES, INC. 2019-10-10 US disclosed
WO-2019154983-A1 ANTIBACTERIAL AND SPERMICIDAL LUBRICANT BCSK BIOCID GMBH (AT) 2019-08-15 WO disclosed
US-20170224824-A1 WARMING PERSONAL LUBRICANT FREE FROM PRESERVATIVES GUY & O'NEILL, INC. 2017-08-10 US disclosed
EP-2108359-B1 WARMING AND NONIRRITATING LUBRICANT COMPOSITIONS RECKITT BENCKISER BRANDS LTD (GB) 2017-06-21 EP disclosed
WO-1994008536-A9 VAGINAL SPONGE DELIVERY SYSTEM 1994-08-04 WO disclosed
US-5326788-A Inactivating viruses with aromatic polycyclic diones NEW YORK UNIVERSITY (US) 1994-07-05 US disclosed
WO-1994008536-A1 VAGINAL SPONGE DELIVERY SYSTEM GYNETECH LABORATORIES, INC. (US) 1994-04-28 WO disclosed
EP-0409957-A4 BIOLOGICAL FLUIDS PURIFICATION SYSTEMS 1993-01-07 EP disclosed
US-5149718-A BIOLOGICAL FLUID PURIFICATION SYSTEM NEW YORK UNIVERSITY (US) 1992-09-22 US disclosed
EP-0409957-A1 BIOLOGICAL FLUIDS PURIFICATION SYSTEMS NEW YORK UNIVERSITY (US) 1991-01-30 EP disclosed
US-4972849-A Condom (sanitary contraception device) PARK YONG YEON (KR) 1990-11-27 US disclosed
WO-1990007876-A1 BIOLOGICAL FLUIDS PURIFICATION SYSTEMS NEW YORK UNIVERSITY (US) 1990-07-26 WO disclosed
US-4707362-A Sustained release composition BIOTEK, INC. (US) 1987-11-17 US disclosed
US-4228797-A Intravaginal contraception method DICKEY RICHARD P 1980-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210038637-A1 ANTIBACTERIAL AND SPERMICIDAL LUBRICANT ACR, NASP, SMPD1 GPR84 1333/4885PPARG 1818/4885PPARD 1074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.